Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL20677215

NCCOCCOCCNC(=O)CCCCCN1C(=O)C=CC1=O.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 4/20 0.44
▸ PTGS2 P35354 4/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ HTT P42858 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ NPY1R P25929 1/20 0.37
▸ NPY4R P50391 1/20 0.37
▸ MGLL Q99685 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ TLR9 Q9NR96 1/20 0.36
▸ FAAH O00519 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL20677193 1.00 PTGS1 (0.44) PTGS1PTGS2SMN1; SMN2HTTHPGD
SCHEMBL17841851 0.92 HTT (0.49) PTGS1PTGS2SMN1; SMN2HTTHPGD
SCHEMBL17841853 0.92 HTT (0.49) PTGS1PTGS2SMN1; SMN2HTTHPGD
Trifluoroacetic Acid SCHEMBL29467754 0.91 MGLL (0.40) PTGS1PTGS2NPY1RNPY4RMGLL
Ethane SCHEMBL20263693 0.90 HTT (0.50) PTGS1PTGS2SMN1; SMN2HTTHPGD
SCHEMBL16580150 0.88 MGLL (0.45) PTGS1PTGS2SMN1; SMN2HTTHPGD
Trifluoroacetic Acid SCHEMBL20263649 0.84 PKM (0.41) SMN1; SMN2NPY1RNPY4RMGLLALDH1A1
SCHEMBL20550737 0.84 PTGS1 (0.52) PTGS1PTGS2SMN1; SMN2HTTHPGD
SCHEMBL28641457 0.84 PTGS1 (0.52) PTGS1PTGS2SMN1; SMN2HTTHPGD
Trifluoroacetic Acid SCHEMBL28645461 0.83 PKM (0.41) SMN1; SMN2NPY1RNPY4RMGLLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114917361-A Antibody Drug Conjugates (ADC) and antibody prodrug conjugates (APDC) with enzyme cleavable groups 拜耳医药股份有限公司 2022-08-19 — — CN disclosed
CN-107635586-B Antibody-drug conjugates (ADC) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies 拜耳医药股份有限公司 2021-09-24 — — CN disclosed
EP-3432934-A1 PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE GROUPS Bayer Pharma Aktiengesellschaft (DE) 2019-01-30 — — EP disclosed
Send feedback